Union Square Park Sells Mohawk Industries Stock

Union Square Park sold its entire 40,000-share position in Mohawk Industries in Q4, removing a stake that was valued at $5.1M (about 1.8% of the fund's AUM) in the prior quarter. Mohawk shares are ~62% off their peak and adjusted revenue fell 3% YoY last quarter; management expects market conditions to improve modestly but housing weakness persists. The manager reallocated into other names (adding to RH), so the 13F sale signals portfolio repositioning rather than company-specific distress and is unlikely to materially move the stock on its own.

Analysis

Union Square’s exit is a signal more than a balance-sheet shock: it increases the marginal supply of a cyclical name at the moment macro uncertainty around housing persists, which magnifies downside gamma for holders without conviction. The move also tightens the set of buy-side owners to those who explicitly underwrite a housing recovery, raising the probability that next weak print triggers expedited re-rating rather than patient holding.

At an industry level, the forced rotation favors differentiated, brand-driven players and vertically integrated manufacturers with better pricing power and lower working-capital cyclicality; commodity-exposed peers will feel margin pressure sooner if volumes stay soft. The fund’s reallocation toward higher-end consumer names suggests a bifurcating recovery—luxury renovation demand could outpace broader housing recovery, creating asymmetric returns within building-products suppliers.

Key catalysts to watch over the next 3–12 months are: (1) monthly housing starts and renovation-sourced retail sales, (2) guidance on backlog and inventory turns from peer reports, and (3) resin/polymer feedstock price moves that directly compress or expand gross margins. Tail risks: a sharper-than-expected mortgage-rate tail event or retailer inventory destock could drive another leg down quickly; conversely, a sustainable decline in mortgage rates or a stimulus-led housing impulse would likely reverse the current negative bias within two to four quarters.

Key Decisions for Investors

• Short MHK via defined-risk put spread (size 2–4% portfolio notional): buy a 9–12 month put spread roughly 25%/45% OTM (pay small premium to cap loss). Target 2:1 payoff if MHK falls ~20–30% over 6–12 months; cut if share recovery >15% from entry within 3 months.
• Pair trade — long RH / short MHK (market-value neutral, 0.75–1.25x ratio): horizon 6–12 months to express premium-segmentation thesis. Risk: pair underperforms if broad housing demand rebounds uniformly; target asymmetric return of +25% on pair if RH outperforms by 40% vs MHK down 20%.
• Tactical long TDOC (buy stock or buy-call spread, 12–24 month): exposure to secular telehealth growth and defensive demand. Position size 1–3% notional; target total return 30–50% if execution and margin expansion continue, stop-loss at 20% drawdown.
• Contrarian covered-call entry on MHK for patient income buyers (size 1–2%): accumulate on sustained underperformance and sell 6–9 month calls ~20–30% OTM to collect yield while waiting for cyclical recovery (time horizon 18–36 months). This caps upside but materially improves IRR if the housing trough proves long-lived.